So the pharma landscape continues to evolve. It’s interesting to witness the changes taking place, many of them using technology to improve the way medicine and drugs are administered, monitored and prescribed
We can’t escape the personal at the moment. Personalised medicine has attracted much attention over the last year with cost savings and improved patient outcomes being put forward as examples of the benefits it can offer. Recent reports have highlighted its potential role in the treatment of cancer as researchers have found that the genetic makeup of tumours means we could soon see treatment tailor-made for individual patients.